Related Experiment Video
Updated: Aug 10, 2026

Development of a More Sensitive and Specific Chromogenic Agar Medium for the Detection of Vibrio parahaemolyticus and Other Vibrio Species
Published on: November 8, 2016
Inhibition of MAPK signaling pathways by VopA from Vibrio parahaemolyticus
Jennifer E Trosky1, Sohini Mukherjee, Dara L Burdette
1Department of Molecular Biology, University of Texas Southwestern Medical School, Dallas, Texas 75390-9148, USA.
Abstract:
During infection, bacterial pathogens utilize a type III secretion system to inject effectors into the cytoplasm of a target cell where they disrupt the defense system of the host cell. Vibrio parahaemolyticus, a causative agent of gastroenteritis endemic in Southeast Asia, has a type III secretion system that encodes a novel member of the YopJ-like protein effector family, VopA (Vibrio outer protein A). Our studies revealed that Vibrio VopA encodes an evolutionarily conserved activity that is extremely potent and requires an intact catalytic site to abrogate signaling pathways in a manner distinct from that of other YopJ-like effectors. We observed that VopA efficiently inhibits the MAPK signaling pathways but not the NFkappaB pathway in mammalian cells. When expressed in yeast, VopA induces a growth arrest phenotype and also blocks yeast MAPK signaling pathways. Our observations provide insight into the immense diversity of targets utilized by YopJ-like effectors to manipulate eukaryotic signaling machineries that are important for the response and survival of the host cell during infection and/or symbiosis.
Insights
Vibrio parahaemolyticus uses VopA, a potent bacterial effector, to disrupt host cell signaling. This study reveals VopA
Area of Science:
- Microbiology
- Cell Biology
- Molecular Biology
Background:
- Bacterial pathogens employ type III secretion systems (T3SS) to inject effector proteins into host cells.
- These effectors manipulate host cell functions, aiding pathogen survival and virulence.
- Vibrio parahaemolyticus, a common cause of gastroenteritis, possesses a T3SS with novel effectors.
Purpose of the Study:
- To characterize the novel YopJ-like effector VopA from Vibrio parahaemolyticus.
- To investigate the conserved activity and target specificity of VopA.
- To understand VopA's mechanism in disrupting host cell signaling pathways.
Main Methods:
- Expression and functional analysis of VopA in mammalian cells and yeast.
- Assessment of VopA's impact on MAPK and NF-kappaB signaling pathways.
- Investigation of the requirement for an intact catalytic site for VopA activity.
Main Results:
- VopA exhibits potent, evolutionarily conserved activity requiring an intact catalytic site.
- VopA specifically inhibits MAPK signaling pathways in mammalian cells.
- VopA induces growth arrest and inhibits MAPK signaling in yeast.
- VopA's inhibitory mechanism differs from other YopJ-like effectors.
Conclusions:
- VopA is a potent T3SS effector that distinctively targets and inhibits MAPK signaling pathways.
- VopA's conserved activity highlights the diverse strategies bacterial effectors use to manipulate host cell machinery.
- Understanding VopA provides insights into host-pathogen interactions and host defense mechanisms.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
cAMP-dependent Protein Kinase Pathways
Regulation of Bacterial Virulence
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Viral Protein Synthesis

